Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C virus and the lung: implications for therapy.

Jonathan Moorman1, Mustafa Saad, Semaan Kosseifi

  • 1Division of Infectious Diseases, Department of Internal Medicine, James H. Quillen VAMC and James H. Quillen College of Medicine, East Tennessee State University, Box 70622, Johnson City, TN 37614, USA. moorman@mail.etsu.edu

Chest
|October 21, 2005
PubMed
Summary

Hepatitis C virus (HCV) infection impacts over 4 million Americans, leading to chronic liver disease and potentially affecting lung health. This review explores HCV

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Parkinson's disease severity and treatment classification in interpreting bisphosphonate-associated fracture risk.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2026
Same author

Trends in atrial fibrillation/atrial flutter and cirrhosis-related mortality in the United States from 1999 to 2020: a CDC WONDER analysis.

Annals of medicine and surgery (2012)·2026
Same author

Polygenic Risk Scores in Chronic Hepatitis B-Related HCC: Promise Beyond Conventional Models?

Journal of gastroenterology and hepatology·2026
Same author

LTE: from early gains to lasting outcomes-expanding ANP-led models for hip fracture recovery.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2025
Same author

Osteonecrosis: A disabling disease not to be ignored in asthma and atopic conditions.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2024
Same author

Multicomponent Approaches to Reduce Multidrug-Resistant Organisms in Critical Care: Determining the Ideal Strategy.

Journal of epidemiology and global health·2024

Area of Science:

  • Hepatology and Pulmonology
  • Viral Infections
  • Internal Medicine

Background:

  • Hepatitis C virus (HCV) infection is a significant public health concern in the US, affecting over 4 million individuals.
  • Chronic HCV infection commonly leads to liver disease, including cirrhosis and hepatoma.
  • Emerging evidence highlights HCV's role in extrahepatic manifestations, particularly affecting the lungs.

Purpose of the Study:

  • To review the emerging clinical data on the association between HCV infection and lung disease.
  • To describe the various pulmonary manifestations associated with chronic HCV infection.
  • To outline current therapeutic strategies for managing lung complications in HCV patients.

Main Methods:

  • Review of current clinical data and literature on HCV and pulmonary disease.

Related Experiment Videos

  • Analysis of primary and secondary effects of HCV on lung function.
  • Synthesis of information on treatment options for HCV-related lung conditions.

    • Main Results:

    • HCV infection has recognized primary effects on lung function.
    • Secondary pulmonary complications arise from progressive liver disease and HCV treatment.
    • A spectrum of lung manifestations is associated with chronic HCV infection.

    Conclusions:

    • HCV infection plays a role in the development of lung disease.
    • Pulmonary complications are a significant, often overlooked, aspect of chronic HCV.
    • Management requires addressing both the viral infection and its respiratory sequels.